Annual CFO
-$8.06 M
+$1.54 M+16.05%
31 December 2023
Summary:
Processa Pharmaceuticals annual cash flow from operations is currently -$8.06 million, with the most recent change of +$1.54 million (+16.05%) on 31 December 2023. During the last 3 years, it has fallen by -$4.92 million (-156.53%). PCSA annual CFO is now -18565.05% below its all-time high of -$43.20 thousand, reached on 31 December 2016.PCSA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$3.60 M
-$256.80 K-7.68%
30 September 2024
Summary:
Processa Pharmaceuticals quarterly cash flow from operations is currently -$3.60 million, with the most recent change of -$256.80 thousand (-7.68%) on 30 September 2024. Over the past year, it has dropped by -$1.84 million (-104.59%). PCSA quarterly CFO is now -12437.67% below its all-time high of $29.20 thousand, reached on 30 September 2020.PCSA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$11.12 M
-$1.84 M-19.85%
30 September 2024
Summary:
Processa Pharmaceuticals TTM cash flow from operations is currently -$11.12 million, with the most recent change of -$1.84 million (-19.85%) on 30 September 2024. Over the past year, it has dropped by -$2.68 million (-31.82%). PCSA TTM CFO is now -202303.64% below its all-time high of $5500.00, reached on 31 March 2017.PCSA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCSA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.1% | -104.6% | -31.8% |
| 3 y3 years | -156.5% | -132.0% | -34.5% |
| 5 y5 years | -117.5% | -399.1% | -327.6% |
PCSA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -156.5% | +16.1% | -132.0% | at low | -39.0% | at low |
| 5 y | 5 years | -193.2% | +16.1% | <-9999.0% | at low | -650.7% | at low |
| alltime | all time | <-9999.0% | +16.1% | <-9999.0% | at low | <-9999.0% | at low |
Processa Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.60 M(+7.7%) | -$11.12 M(+19.8%) |
| June 2024 | - | -$3.35 M(+63.3%) | -$9.28 M(+16.0%) |
| Mar 2024 | - | -$2.05 M(-3.5%) | -$8.00 M(-0.8%) |
| Dec 2023 | -$8.06 M(-16.1%) | -$2.12 M(+20.6%) | -$8.06 M(-4.4%) |
| Sept 2023 | - | -$1.76 M(-14.7%) | -$8.44 M(-12.6%) |
| June 2023 | - | -$2.06 M(-2.3%) | -$9.65 M(-2.7%) |
| Mar 2023 | - | -$2.11 M(-15.3%) | -$9.92 M(+3.2%) |
| Dec 2022 | -$9.61 M(+10.2%) | -$2.50 M(-16.0%) | -$9.61 M(-2.3%) |
| Sept 2022 | - | -$2.97 M(+27.6%) | -$9.83 M(+16.9%) |
| June 2022 | - | -$2.33 M(+29.3%) | -$8.41 M(+1.6%) |
| Mar 2022 | - | -$1.80 M(-33.9%) | -$8.28 M(-5.1%) |
| Dec 2021 | -$8.72 M(+177.3%) | -$2.73 M(+75.6%) | -$8.72 M(+5.5%) |
| Sept 2021 | - | -$1.55 M(-29.2%) | -$8.27 M(+23.7%) |
| June 2021 | - | -$2.19 M(-2.2%) | -$6.68 M(+38.1%) |
| Mar 2021 | - | -$2.24 M(-1.4%) | -$4.84 M(+54.0%) |
| Dec 2020 | -$3.14 M(+14.3%) | -$2.28 M(-7892.5%) | -$3.14 M(+112.2%) |
| Sept 2020 | - | $29.20 K(-108.3%) | -$1.48 M(-33.6%) |
| June 2020 | - | -$350.60 K(-35.8%) | -$2.23 M(-17.0%) |
| Mar 2020 | - | -$546.50 K(-10.9%) | -$2.69 M(-2.2%) |
| Dec 2019 | -$2.75 M(-25.8%) | -$613.50 K(-15.0%) | -$2.75 M(+5.7%) |
| Sept 2019 | - | -$721.80 K(-10.6%) | -$2.60 M(-10.0%) |
| June 2019 | - | -$807.50 K(+32.9%) | -$2.89 M(-11.0%) |
| Mar 2019 | - | -$607.40 K(+30.9%) | -$3.25 M(-12.4%) |
| Dec 2018 | -$3.71 M | -$464.00 K(-54.1%) | -$3.71 M(-20.2%) |
| Sept 2018 | - | -$1.01 M(-13.2%) | -$4.65 M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$1.16 M(+8.9%) | -$3.81 M(+40.0%) |
| Mar 2018 | - | -$1.07 M(-23.9%) | -$2.72 M(+64.5%) |
| Dec 2017 | -$1.65 M(+3730.1%) | -$1.40 M(+708.6%) | -$1.65 M(+543.8%) |
| Sept 2017 | - | -$173.70 K(+132.5%) | -$257.00 K(+285.9%) |
| June 2017 | - | -$74.70 K(+4568.8%) | -$66.60 K(-1310.9%) |
| Mar 2017 | - | -$1600.00(-77.1%) | $5500.00(-112.7%) |
| Dec 2016 | -$43.20 K(-95.0%) | -$7000.00(-141.9%) | -$43.30 K(-47.5%) |
| Sept 2016 | - | $16.70 K(-742.3%) | -$82.40 K(-43.7%) |
| June 2016 | - | -$2600.00(-94.8%) | -$146.30 K(-65.2%) |
| Mar 2016 | - | -$50.40 K(+9.3%) | -$420.20 K(-51.8%) |
| Dec 2015 | -$871.90 K(-67.6%) | -$46.10 K(-2.3%) | -$871.90 K(-32.0%) |
| Sept 2015 | - | -$47.20 K(-82.9%) | -$1.28 M(-27.8%) |
| June 2015 | - | -$276.50 K(-44.9%) | -$1.77 M(-19.6%) |
| Mar 2015 | - | -$502.10 K(+10.2%) | -$2.21 M(-18.0%) |
| Dec 2014 | -$2.69 M(+6.0%) | -$455.60 K(-15.7%) | -$2.69 M(-0.3%) |
| Sept 2014 | - | -$540.20 K(-23.7%) | -$2.70 M(-5.9%) |
| June 2014 | - | -$708.10 K(-28.3%) | -$2.87 M(-2.2%) |
| Mar 2014 | - | -$987.70 K(+113.6%) | -$2.93 M(+15.5%) |
| Dec 2013 | -$2.54 M(+34.2%) | -$462.50 K(-34.8%) | -$2.54 M(-6.8%) |
| Sept 2013 | - | -$709.30 K(-8.3%) | -$2.72 M(+2.0%) |
| June 2013 | - | -$773.90 K(+30.5%) | -$2.67 M(+16.7%) |
| Mar 2013 | - | -$593.00 K(-8.5%) | -$2.29 M(+21.0%) |
| Dec 2012 | -$1.89 M | -$647.80 K(-1.3%) | -$1.89 M(+52.0%) |
| Sept 2012 | - | -$656.20 K(+67.3%) | -$1.24 M(+111.5%) |
| June 2012 | - | -$392.20 K(+99.9%) | -$588.40 K(+199.9%) |
| Mar 2012 | - | -$196.20 K | -$196.20 K |
FAQ
- What is Processa Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual CFO year-on-year change?
- What is Processa Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly CFO year-on-year change?
- What is Processa Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals TTM CFO year-on-year change?
What is Processa Pharmaceuticals annual cash flow from operations?
The current annual CFO of PCSA is -$8.06 M
What is the all time high annual CFO for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual cash flow from operations is -$43.20 K
What is Processa Pharmaceuticals annual CFO year-on-year change?
Over the past year, PCSA annual cash flow from operations has changed by +$1.54 M (+16.05%)
What is Processa Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of PCSA is -$3.60 M
What is the all time high quarterly CFO for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly cash flow from operations is $29.20 K
What is Processa Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, PCSA quarterly cash flow from operations has changed by -$1.84 M (-104.59%)
What is Processa Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of PCSA is -$11.12 M
What is the all time high TTM CFO for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high TTM cash flow from operations is $5500.00
What is Processa Pharmaceuticals TTM CFO year-on-year change?
Over the past year, PCSA TTM cash flow from operations has changed by -$2.68 M (-31.82%)